Health sector experts in Jordan have called for stronger governance of the national healthcare system and improved coordination among institutions. Their objective is to enhance spending efficiency and guarantee that patients receive necessary medicines and services promptly and to the required standard. These demands emerged during the launch conference for a policy paper titled "Towards a Patient-Centered Pharmaceutical System in Jordan: From Drug Availability to Ensuring Access." The Phoenix Center for Sustainable Development prepared the policy paper. The experts emphasized that a fundamental re-evaluation of current practices is essential to address persistent challenges within the sector. Their collective appeal shows a critical need for systemic changes to optimize healthcare delivery across the Hashemite Kingdom.
Systemic Challenges Identified
Jordan allocates approximately 9 percent of its gross domestic product to healthcare. Despite this level of investment, outcomes in service efficiency, quality, and accessibility reportedly fall short of what such spending should produce. The Phoenix Center for Sustainable Development's policy paper identified core problems within the system, including issues with resource allocation and management, alongside significant governance gaps. These findings suggest that while financial commitment is substantial, its impact is diluted by inefficiencies and structural deficiencies. The experts at the conference reiterated that improving the overall health outcomes for the Jordanian population hinges on addressing these foundational issues.
These governance gaps encompass fragmented leadership, the presence of multiple decision-making centers, and limited coordination, integration, and information-sharing across the healthcare landscape. This fragmentation often leads to duplicated efforts, resource wastage, and inconsistent policy implementation, ultimately affecting patient care. The policy paper further specified that the core issue is not a generalized drug shortage within Jordan. Instead, it noted a potential gap between a drug's presence within the system and its actual availability to the patient at the point of service, indicating a distribution or access challenge rather than a supply problem. This distinction is key, as it shifts the focus from procurement to logistics and patient-centric delivery mechanisms. The experts stressed that improving access to medicines requires a nuanced understanding of these distribution bottlenecks.
Patient Trust and Access Gaps
Participants in the discussion noted a decline in public trust in primary healthcare services. This declining trust reportedly leads patients to bypass local health centers, opting instead for direct referral to hospitals, which can strain secondary care facilities. This behavior not only overburdens specialized services but also undermines the role of primary care as the first point of contact for routine health issues, potentially delaying early diagnosis and preventive care. The experts noted that rebuilding this trust is critical for the effective functioning of the entire healthcare ecosystem.
The policy paper from the Phoenix Center for Sustainable Development recommended the creation of a national drug-demand intelligence system. Such a system would aim to better predict and manage the need for pharmaceuticals across the country. By leveraging data analytics and forecasting tools, this intelligence system could optimize inventory levels and ensure that essential medicines are available where and when they are most needed. This proactive approach would help mitigate the access challenges identified.
Additionally, the paper called for the implementation of electronic inventory systems. These systems are intended to function as early-warning tools, alerting health authorities when specific medicines are at risk of running out, thereby helping to prevent potential shortages and ensure consistent patient access. Such digital solutions would provide real-time visibility into stock levels, allowing for timely interventions and more efficient supply chain management. The experts at the conference supported these technological advancements as key steps towards a more resilient and responsive pharmaceutical system.
Recommendations for Improvement
Improving access to medicine in Jordan requires enhanced governance and integration among existing institutions. Experts recommend greater efficiency in resource utilization and a patient-centric approach to planning and evaluation. This strategy aims to ensure that healthcare services and pharmaceutical provisions are consistently available to those who need them. The proposed reforms are designed to create a more cohesive and accountable healthcare environment, ultimately leading to better health outcomes for all Jordanians. The emphasis on a patient-centered model signifies a shift towards prioritizing individual needs and experiences in the design and delivery of healthcare services.
